Breaking News Instant updates and real-time market news.

NKE

Nike

$53.55

0.515 (0.97%)

, UA

Under Armour

$16.02

-0.32 (-1.96%)

10:35
09/12/17
09/12
10:35
09/12/17
10:35

Bernstein says buy Nike, sell Under Armour

Research firm Bernstein started coverage of Nike (NKE) with an Outperform rating and launched coverage of its competitor, Under Armour (UA, UAA), with an Underperform, the equivalent of a sell rating. The firm expects Nike's share gains to continue and predicted that Under Armour would not be able to resume its previous growth rate of above 20% on a consistent basis. NIKE: Nike's innovation, strong R&D, and ability to pay athletes for endorsements will enable its share gains to continue, wrote Bernstein analyst Jamie Merriman. The analyst says that Nike's shift to a direct to consumer model has slowed its growth in North America, but its fundamentals remain strong, as consumers continue to have a positive view of its products. Merriman expects the company's North American sales to beat expectations by 3.4% in fiscal 2018 and 5.6% in fiscal 2019. Also likely to push the stock significantly higher are the company's revenue and earnings growth, the analyst wrote. She placed a $69 price target on the name. UNDER ARMOUR: The company's new categories and channels are both problematic, according to Merriman. Its direct to consumer footwear sales remain anemic, as its products in that category are rated below those of its competitors, she wrote. Meanwhile, Under Armour has created difficulties in its wholesale business by delivering products to Kohl's (KSS) that are more similar to its merchandise at Dick's Sporting (DKS) "than we would expect," Merriman stated. Dick's is looking to lower the prices it charges for Under Armour's products, which could damage the apparel maker's brand, according to the analyst. Predicting that Under Armour's 2017 and 2018 results would come in below expectations, she set a $14 price target on the name. PRICE ACTION: In morning trading, Nike rose 1% to $53.62 and Under Armour lost 0.5% to $17.35.

NKE

Nike

$53.55

0.515 (0.97%)

UA

Under Armour

$16.02

-0.32 (-1.96%)

UAA

Under Armour

$17.34

-0.08 (-0.46%)

DKS

Dick's Sporting

$27.31

0.21 (0.77%)

KSS

Kohl's

$44.19

0.81 (1.87%)

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 09

    Nov

NKE Nike
$53.55

0.515 (0.97%)

09/12/17
BERN
09/12/17
INITIATION
Target $69
BERN
Outperform
Nike initiated with an Outperform at Bernstein
Bernstein analyst Jamie Merriman started Nike with an Outperform and $69 price target saying it is the best in class athletic apparel and footwear brand and the leader in market share globally. Given the pipeline of innovation, the strength of the R&D platform and the ability to invest in athletes driven by the size of the balance sheet, the analyst believes share gains will continue.
09/01/17
OPCO
09/01/17
NO CHANGE
Target $68
OPCO
Outperform
lululemon multiple expansion warranted after Q2 results, says Oppenheimer
Oppenheimer analyst Anna Andreeva believes multiple expansion for shares of lululemon (LULU) is warranted following last night's Q2 results. Despite an intensifying promotional backdrop in athletic, lululemon's "powerful brand equity with extremely loyal consumer" posted top-line acceleration, Andreeva tells investors in a post-earnings research note. The retailer's valuation is in line with Nike (NKE) despite "far superior" top-line growth, the analyst contends. She raised her estimates and keeps an Outperform rating on lululemon.
08/29/17
MSCO
08/29/17
NO CHANGE
Target $50
MSCO
Overweight
Foot Locker problems fixable, mostly fashion-related, says Morgan Stanley
Morgan Stanley analyst Jay Sole made his case for keeping an Overweight rating on Foot Locker (FL) in a new note to investors, arguing that the problems that caused the company's "very disappointing" Q2 results were not structural, but "mostly fashion-related" and fixable. He still sees the stock's risk/reward balance skewed to the upside, based on his belief that Foot Locker can defend itself versus Amazon (AMZN), Nike's (NKE) new product pipeline should eventually improve and brands' quicker speed to market "could be a game-changer." However, Sole has lowered his price target on Foot Locker shares to $50 from $65.
09/12/17
09/12/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. DowDuPont (DWDP) initiated with an Outperform at Macquarie. 2. Bunge (BG) initiated with a Neutral at Baird. 3. Rite Aid (RAD) initiated with a Hold at Loop Capital. 4. Nike (NKE) was initiated with an Outperform at Bernstein, while Under Armour (UA) was initiated with an Underperform. 5. Houlihan Lokey (HLI) initiated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
UA Under Armour
$16.02

-0.32 (-1.96%)

08/02/17
08/02/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) downgraded to Neutral from Buy at Citi with analyst Kate McShane citing yesterday's guide-down, the shares look "too expensive for investors to jump into the name nearer-term." 2. Burlington Stores (BURL) downgraded to Neutral from Outperform at Credit Suisse with analyst Christian Buss saying that although the fundamentals of the company remain healthy, he sees limited upside to valuation as the multiples stay elevated despite more moderate industry growth prospects. 3. Big 5 Sporting (BGFV) downgraded to Hold from Buy at Deutsche Bank with analyst Mike Baker saying he expected Big Five's sales gains following The Sports Authority liquidation would decelerate at some point, but he notes that "trends fell off faster and to a greater extent than we suspected." 4. Ultimate Software (ULTI) downgraded to Hold from Buy at Deutsche Bank with analyst Nandan Amladi calling the second quarter results "mixed" and prefers to move to the sidelines until growth returns to the mid-20s target and leverage returns to the model. 5. ResMed (RMD) was downgraded to Neutral from Buy at BofA/Merrill and to Neutral from Outperform at Credit Suisse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/12/17
BERN
09/12/17
INITIATION
Target $14
BERN
Underperform
Under Armour initiated with an Underperform at Bernstein
Bernstein analyst Jamie Merriman started Under Armour with an Underperform rating and $14 price target as he believes it is now in "growth purgatory." While growth will remain in the high single digits-low double digits, the analyst does not believe recovering back to over 20% will occur on a sustainable basis.
08/18/17
SBSH
08/18/17
NO CHANGE
Target $81
SBSH
Buy
Foot Locker results and guidance 'greatly disappoints,' says Citi
Citi analyst Kate McShane says Foot Locker's (FL) Q2 results and outlook "greatly disappoints." The company posted its first negative comp since Q4 of 2009, McShane tells investors in a post-earnings research note. Along with Foot Locker, the analyst expects weakness in shares of Nike (NKE) and Finish Line (FINL) as well as Under Armour (UAA, UA) and Dick's Sporting Goods (DKS). McShane currently has a Buy rating on Foot Locker.
UAA Under Armour
$17.34

-0.08 (-0.46%)

08/02/17
SBSH
08/02/17
DOWNGRADE
Target $21
SBSH
Neutral
Under Armour downgraded to Neutral from Buy at Citi
Citi analyst Kate McShane downgraded Under Armour (UAA) and lowered her price target for the shares to $21 from $25. Following yesterday's guide-down, the shares look "too expensive for investors to jump into the name nearer-term," McShane tells investors. She expects the stock will continue trading in a tight range until the end of the year. Under Armour closed yesterday down 9%, or $1.72, to $18.30.
DKS Dick's Sporting
$27.31

0.21 (0.77%)

08/24/17
08/24/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Teva (TEVA) downgraded to Underperform from Neutral at Credit Suisse by analyst Vamil Divan, saying that while Teva has dramatically reduced 2017 guidance, the core challenges they are facing should not fade anytime soon. The analyst pointed out that pricing pressure and increased competition in the U.S. generics business will remain, the appointment of a full-time CEO is still pending and the threat of generic competition to Copaxone 40mg still looms. 2. Lowe's (LOW) downgraded to Market Perform from Outperform at BMO Capital by analyst Wayne Hood based on the company's results and guidance which he said were "disappointing." The analyst expects the company's profitability to remain "challenged" going forward. 3. Dick's Sporting (DKS) downgraded to Market Perform from Outperform at Cowen, saying it had overestimated the company's ability to achieve its prior guidance and maintain its profitability. Cowen pointed to a number of headwinds for Dick's, including increasing digital competition and the negative side of industry cyclical trends. 4. J.M. Smucker (SJM) downgraded to Neutral from Overweight at JPMorgan. 5. LaSalle Hotel (LHO) downgraded to Neutral from Outperform at Boenning & Scattergood by analyst Floris van Dijkum citing recent share outperformance and potential declining comparable EBITDA that could pressure future NAV. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/24/17
COWN
08/24/17
DOWNGRADE
Target $28
COWN
Market Perform
Dick's Sporting downgraded to Market Perform at Cowen
As previously reported, Cowen analyst John Kernan downgraded Dick's Sporting to Market Perform from Outperform citing his overestimation for the company to achieve guidance and maintain profitability in the face of structural and cyclical headwinds. He also noted the competition from other apparel companies, merchandising margin pressure, and shipping cost pressure. Kernan lowered his price target to $28 from $31 on Dick's Sporting shares.
08/24/17
COWN
08/24/17
DOWNGRADE
COWN
Market Perform
Dick's Sporting downgraded to Market Perform from Outperform at Cowen
08/29/17
SBSH
08/29/17
DOWNGRADE
Target $5
SBSH
Sell
Finish Line downgraded to Sell from Neutral at Citi
Citi analyst Kate McShane downgraded Finish Line (FINL) to Sell and cut her price target for the shares to $5 from $14 after the company preannounced a Q2 miss and cut its outlook for the year. The shares in premarket trading are down 26%, or $2.71, to $7.71. The marketplace for athletic footwear became more promotional as Q2 progressed but Finish Line's earnings reduction appears worse than the market expected, McShane tells investors in a research note. She believes the competitive environment among athletic retailers "has only become more difficult" and that Finish Line suffers from being a smaller mall- based chain relative to Dick's Sporting Goods (DKS) and Foot Locker (FL). FBR Capital this morning also downgraded Finish Line.
KSS Kohl's
$44.19

0.81 (1.87%)

09/06/17
BARD
09/06/17
NO CHANGE
Target $43
BARD
Neutral
Baird speculates if Kohl's could be takeover target for Amazon
After Kohl's (KSS) and Amazon (AMZN) announced a partnership this morning that will see Kohl's roll out a "smart home experience" in 10 stores and begin selling Amazon Alexa devices, Baird analyst Mark Altschwager called it an "If you can't beat them, join them" move and wondered if the news could "foreshadow a more significant relationship down the road," though he acknowledged the idea to be "pure speculation." He said that a brick & mortar apparel acquisition or strategic partnership could align with Amazon's rising fashion ambitions. Altschwager keeps a Neutral rating and $43 price target on Kohl's, adding that a shifting narrative around Amazon could improve sentiment and raise the stock's valuation.
09/07/17
ROTH
09/07/17
NO CHANGE
Target $48
ROTH
Buy
Roth Capital still a buyer of Alarm.com on Amazon.com, Kohl's headline risk
Roth Capital analyst Darren Aftahi notes that Amazon's (AMZN) in-store presence with Kohl's (KSS) should provide another platform promoting voice-enabled devices to consumers, notably their smart home functionality. While headline risk to Alarm.com (ALRM), the analyst feels Amazon lacks the "operating system" capability to connect various smart devices into a unified platform for a single means to control smart home devices. Aftahi believes Alarm.com's ability to integrate its software, enabling devices to talk to one another is a key differentiator versus Amazon, along with its 6k independent service provider network. He reiterates a Buy rating and $48 price target on Alarm.com's shares
08/11/17
08/11/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) upgraded to Overweight from Equal Weight at Stephens with analyst Ben Bienvenu saying that the company's multi-year investments have led to a better in-store experience, which he sees continuing to drive momentum. 2. Kohl's (KSS) upgraded to Neutral from Underperform at Credit Suisse. 3. Huntington Bancshares (HBAN) upgraded to Overweight from Neutral at Piper Jaffray with analyst Kevin Barker saying the "disappointing" expense guidance has lowered expectations while Huntington should grow earnings faster than any regional bank peer in fiscal 2018 and fiscal 2019. 4. Axalta Coating (AXTA) upgraded to Overweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas saying the 16% pullback over the past three weeks has created an investment opportunity. 5. Perrigo (PRGO) upgraded to Neutral from Sell at Goldman Sachs with analyst Jami Rubin saying the quarterly results may mark the beginning of inflection towards stabilization in the Rx business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/10/17
FBCO
08/10/17
UPGRADE
FBCO
Neutral
Kohl's upgraded to Neutral from Underperform at Credit Suisse

TODAY'S FREE FLY STORIES

FOXA

21st Century Fox

$26.88

0.12 (0.45%)

, ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

20:04
09/24/17
09/24
20:04
09/24/17
20:04
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

FOXA

21st Century Fox

$26.88

0.12 (0.45%)

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

ORCL

Oracle

$48.16

0.19 (0.40%)

GPRO

GoPro

$10.75

-0.19 (-1.74%)

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

SIX

Six Flags

$58.96

1.14 (1.97%)

HMC

Honda

$29.91

0.18 (0.61%)

IRBT

iRobot

$76.14

-3.8 (-4.75%)

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 28

    Sep

  • 28

    Sep

  • 12

    Oct

  • 24

    Oct

  • 08

    Nov

  • 12

    Jan

NVCR

Novocure

$21.50

-0.1 (-0.46%)

18:27
09/24/17
09/24
18:27
09/24/17
18:27
Hot Stocks
Combination of Novocure Optune with Temozolomide demonstrates five-year survival »

Novocure announced today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$102.40

-0.09 (-0.09%)

, CMCSA

Comcast

$38.10

0.63 (1.68%)

17:10
09/24/17
09/24
17:10
09/24/17
17:10
Hot Stocks
Box Office Battle: 'Kingsman: The Golden Circle' easily wins weekend »

"Kingsman: The…

TWX

Time Warner

$102.40

-0.09 (-0.09%)

CMCSA

Comcast

$38.10

0.63 (1.68%)

CMCSK

Comcast

SNE

Sony

$37.50

0.04 (0.11%)

FOX

21st Century Fox

$26.43

0.1 (0.38%)

FOXA

21st Century Fox

$26.88

0.12 (0.45%)

LGF.A

Lionsgate

$31.49

0.24 (0.77%)

DIS

Disney

$98.60

-0.29 (-0.29%)

VIAB

Viacom

$27.64

0.24 (0.88%)

VIA

Viacom

$38.00

-0.2 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 29

    Sep

  • 22

    Oct

  • 26

    Oct

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

16:41
09/24/17
09/24
16:41
09/24/17
16:41
Periodicals
Amazon affiliate to buy stake in Indian retailer Shoppers Stop, Reuters says »

An affiliate of Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

, GOOG

Alphabet

$928.53

-3.92 (-0.42%)

16:37
09/24/17
09/24
16:37
09/24/17
16:37
Periodicals
Internet giants on the defensive in Washington, Reuters says »

Internet giants,…

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

  • 29

    Nov

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

, UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

16:25
09/24/17
09/24
16:25
09/24/17
16:25
Periodicals
Opposition to new 'Obamacare' repeal bill grows, Reuters reports »

The new proposal by…

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

CNC

Centene

$92.22

1.48 (1.63%)

WCG

WellCare

$167.16

1.1 (0.66%)

CI

Cigna

$182.74

0.61 (0.33%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

AET

Aetna

$153.57

0.18 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

SAP

SAP

$110.27

0.64 (0.58%)

16:11
09/24/17
09/24
16:11
09/24/17
16:11
Hot Stocks
SAP announces acquisition of Gigya »

SAP has announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TATT

TAT Technologies

$10.70

0.05 (0.47%)

, BA

Boeing

$256.45

0.41 (0.16%)

16:03
09/24/17
09/24
16:03
09/24/17
16:03
Hot Stocks
TAT Technologies awarded APU MRO contract for fleet of Boeing, Airbus »

TAT Technologies (TATT),…

TATT

TAT Technologies

$10.70

0.05 (0.47%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

GM

General Motors

$39.42

0.32 (0.82%)

11:43
09/23/17
09/23
11:43
09/23/17
11:43
Periodicals
GM to eliminate shift at Tennessee SUV plant on 'moderating' sales, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.25

0.19 (0.35%)

11:34
09/23/17
09/23
11:34
09/23/17
11:34
Periodicals
Wells Fargo hires law firm to prepare CEO for Senate appearance, Reuters says »

Wells Fargo has hired law…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 13

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

EADSY

Airbus

$23.06

-0.01 (-0.04%)

11:27
09/23/17
09/23
11:27
09/23/17
11:27
Periodicals
Airbus in talks to sell all or part of Premium Aerotec, Reuters says »

Airbus is said to be in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$102.11

0.56 (0.55%)

11:06
09/23/17
09/23
11:06
09/23/17
11:06
Hot Stocks
Quest Diagnostics 'disappointed' with proposed PAMA 2018 Medicare payment rates »

Quest Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

IRBT

iRobot

$76.14

-3.8 (-4.75%)

10:58
09/23/17
09/23
10:58
09/23/17
10:58
Periodicals
iRobot suffering after onslaught of SharkNinja cheaper models, Barron's says »

In a follow up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47
Periodicals
Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says »

As everyday items get…

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UTX

United Technologies

$115.01

0.51 (0.45%)

, COL

Rockwell Collins

$130.48

0.09 (0.07%)

10:42
09/23/17
09/23
10:42
09/23/17
10:42
Periodicals
Major aircraft makers, suppliers face off, Barron's says »

While United Technologies…

UTX

United Technologies

$115.01

0.51 (0.45%)

COL

Rockwell Collins

$130.48

0.09 (0.07%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

GPRO

GoPro

$10.75

-0.19 (-1.74%)

10:33
09/23/17
09/23
10:33
09/23/17
10:33
Periodicals
Key events may create 'short squeeze' in GoPro stock, Barron's says »

GoPro, a heavily shorted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.91

0.18 (0.61%)

, RACE

Ferrari

$113.47

-0.1 (-0.09%)

10:17
09/23/17
09/23
10:17
09/23/17
10:17
Periodicals
Honda $200,000 Acura NSX lacks Ferrari 'raw appeal,' Barron's says »

Acura, Honda's (HMC)…

HMC

Honda

$29.91

0.18 (0.61%)

RACE

Ferrari

$113.47

-0.1 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.16

0.19 (0.40%)

10:07
09/23/17
09/23
10:07
09/23/17
10:07
Periodicals
Oracle shares could return 20% in a year, Barron's says »

Oracle is a latecomer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.96

1.14 (1.97%)

09:59
09/23/17
09/23
09:59
09/23/17
09:59
Periodicals
Six Flags may have peaked, Barron's says »

Investors have had an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

, AVXS

AveXis

$92.11

-4.03 (-4.19%)

09:51
09/23/17
09/23
09:51
09/23/17
09:51
Periodicals
Gene therapy may be nearing 'major breakthrough,' Baron's says »

Gene therapy is rapidly…

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

  • 22

    Sep

AET

Aetna

$153.57

0.18 (0.12%)

, ANTM

Anthem

$182.86

-0.64 (-0.35%)

09:25
09/23/17
09/23
09:25
09/23/17
09:25
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

AOBC

American Outdoor Brands

$15.01

-0.15 (-0.99%)

RGR

Sturm, Ruger

$51.00

-1.85 (-3.50%)

WMT

Wal-Mart

$79.53

-0.48 (-0.60%)

PEP

PepsiCo

$111.85

-0.95 (-0.84%)

TGT

Target

$58.99

0.66 (1.13%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

TWTR

Twitter

$17.61

0.03 (0.17%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 22

    Oct

  • 24

    Oct

  • 08

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.